Date: March 27, 2024
Time: 7:30am IST, 10:00am SGT, 11:00am KST, 1:00pm AEDT
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to facilitate seamless integration of each stage of the process for effective clinical decision support to manage gene-drug interactions for patients. This webinar will discuss considerations for the technical aspects of the program that requires collaboration between laboratory, pharmacy, and information technology including developing a timeline for implementation, defining costs for program development, and potential to enhance patient care through researching ways to mitigate adverse drug reactions and personalized selection of drug therapy. Additionally, hospital administration support, physician engagement, and an understanding of the healthcare insurance environment, which are vital for a successful program, will be addressed.
Learning Objectives
- Select the correct testing platform.
- Choose the correct test panel.
- Develop a timeline for implementation.
- Define the role of a Pharmacogenetics Counselor.
- Integrate the Informatics.
- Assess the value of preemptive PGx.
Who should attend?
- Laboratory directors
- Pharmacists
- Pathologists
- Physicians, particularly subspecialists in Psychiatry, Neurology, Oncology, and pain management
- Healthcare executives
- Hospital administrators
- Laboratory technicians
- Anyone planning to implement a preemptive pharmacogenetics program
Webinars will be available for unlimited on-demand viewing after live event.
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.